Results 251 to 260 of about 276,548 (307)

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Conformational stability and domain-specific structural features of tumor autoantigens regulate autoantibody epitope propensity. [PDF]

open access: yesProtein Sci
Miyamoto A   +13 more
europepmc   +1 more source

A multi-epitope-based DNA vaccine confers cross-protection against influenza A H1N1 and H3N2 viruses. [PDF]

open access: yesIran J Microbiol
Barkhordari K   +9 more
europepmc   +1 more source

An in silico VAR2CSA-based multi-epitope vaccine candidate (PM-MEV-k1) shows favourable Structural and Immune Simulation parameters for protection against placental malaria

open access: yes
Kwi PN   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy